Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Broda is a biotechnology company specializing in advanced supramolecular drug delivery systems for topical and transdermal applications. The company's proprietary Supramolecular Delivery System (SDS) enhances the solubility, stability, and skin penetration of active pharmaceutical ingredients without the use of traditional surfactants or alcohols. Broda focuses on developing high-performance formulations for dermatology, including treatments for acne, rosacea, and psoriasis, as well as topical pain relief. By leveraging its platform, the company partners with pharmaceutical and personal care firms to optimize the delivery of both existing and new chemical entities. The technology allows for the creation of clear, water-based formulations that improve patient compliance and therapeutic efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Broda Company.